SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
tengy
Lv5
1470 积分
2021-12-01 加入
最近求助
最近应助
互助留言
Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
9天前
已完结
Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non–Small Cell Lung Cancer
2个月前
已完结
Artificial intelligence–powered assessment of pathologic response to neoadjuvant atezolizumab in patients with non-small cell lung cancer: results from the LCMC3 study
3个月前
已完结
Neoadjuvant alectinib in locally advanced lung adenocarcinoma with anaplastic lymphoma kinase rearrangement
3个月前
已完结
A novel intergenic (between REG3A and CTNNA2-AS1)-ALK fusion responds to alectinib in lung adenocarcinoma
4个月前
已完结
Lung Cancer Risk Prediction Models for Asian Ever-Smokers
5个月前
已完结
Lung Cancer Risk Prediction Models for Asian Ever-Smokers
5个月前
已关闭
Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer
8个月前
已完结
Tumor Microenvironment Landscape of NSCLC Reveals Resistance Mechanisms for Programmed Death-Ligand 1 Blockade After Chemoradiotherapy: A Multicenter Prospective Biomarker Study (WJOG11518L:SUBMARINE)
8个月前
已完结
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer
9个月前
已完结
没有进行任何应助
速度真快
2个月前
感谢
3个月前
速度真快
3个月前
感谢
4个月前
感谢
5个月前
没人应助【积分已退回】
5个月前
点赞
8个月前
感谢
9个月前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论